234 related articles for article (PubMed ID: 16865065)
41. Expression of a cathelicidin antimicrobial peptide is augmented in cholesteatoma.
Jung HH; Chae SW; Jung SK; Kim ST; Lee HM; Hwang SJ
Laryngoscope; 2003 Mar; 113(3):432-5. PubMed ID: 12616192
[TBL] [Abstract][Full Text] [Related]
42. Alteration of epidermal differentiation in middle ear cholesteatoma.
Stammberger M; Bujía J; Kastenbauer E
Am J Otol; 1995 Jul; 16(4):527-31. PubMed ID: 8588655
[TBL] [Abstract][Full Text] [Related]
43. Immunohistochemical localization of cytokeratin 19, involucrin and proliferating cell nuclear antigen (PCNA) in cultured human gingival epithelial sheets.
Murata M; Momose M; Okuda K; Ninagawa Y; Ueda M; Yoshie H
J Int Acad Periodontol; 2005 Oct; 7(4):129-34. PubMed ID: 16245643
[TBL] [Abstract][Full Text] [Related]
44. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
Saeger W; Lüdecke B; Lüdecke DK
Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
[TBL] [Abstract][Full Text] [Related]
45. Immunohistochemical study on topoisomerase IIalpha, Ki-67 and cytokeratin-19 in oral lichen planus lesions.
Mattila R; Alanen K; Syrjänen S
Arch Dermatol Res; 2007 Jan; 298(8):381-8. PubMed ID: 17072627
[TBL] [Abstract][Full Text] [Related]
46. The changes in expression of ICAM-3, Ki-67, PCNA, and CD31 in psoriatic lesions before and after methotrexate treatment.
Yazici AC; Tursen U; Apa DD; Ikizoglu G; Api H; Baz K; Tasdelen B
Arch Dermatol Res; 2005 Dec; 297(6):249-55. PubMed ID: 16215763
[TBL] [Abstract][Full Text] [Related]
47. Profile of anti-stratum corneum autoantibodies in patients with aural cholesteatoma.
Bujía J; Stammberger M; Holly A; Kastenbauer E
Am J Otol; 1994 Jul; 15(4):532-5. PubMed ID: 8588609
[TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical localization of cytokeratin 19, involucrin and proliferating cell nuclear antigen (PCNA) in cultured human gingival epithelial sheets.
Murata M; Momose M; Okuda K; Ninagawa Y; Ueda M; Hiromasa Y
J Int Acad Periodontol; 2006 Jan; 8(1):33-8. PubMed ID: 16459887
[TBL] [Abstract][Full Text] [Related]
49. [Role of microvessel density on human middle ear cholesteatoma].
Lin RY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2005 Mar; 40(3):186-9. PubMed ID: 15952567
[TBL] [Abstract][Full Text] [Related]
50. Nature of cell kinetics in psoriatic epidermis.
Doger FK; Dikicioglu E; Ergin F; Unal E; Sendur N; Uslu M
J Cutan Pathol; 2007 Mar; 34(3):257-63. PubMed ID: 17302610
[TBL] [Abstract][Full Text] [Related]
51. Creation of a cholesteatoma model using three-dimensional cultured skin equivalents.
Tanaka Y; Yaguchi Y; Wada K; Kojima H; Moriyama H
Laryngoscope; 2005 Aug; 115(8):1421-7. PubMed ID: 16094116
[TBL] [Abstract][Full Text] [Related]
52. Immunohistochemical investigations of cathepsin D activity in the structures of cholesteatoma.
Chodynicki S; Chyczewski L; Olszewska E
Med Sci Monit; 2002 May; 8(5):BR184-6. PubMed ID: 12011767
[TBL] [Abstract][Full Text] [Related]
53. Analysis of histopathological aspects and bone destruction characteristics in acquired middle ear cholesteatoma of pediatric and adult patients.
Aslıer M; Erdag TK; Sarioglu S; Güneri EA; Ikiz AO; Uzun E; Özer E
Int J Pediatr Otorhinolaryngol; 2016 Mar; 82():73-7. PubMed ID: 26857319
[TBL] [Abstract][Full Text] [Related]
54. Immunohistochemical study on proliferative activity of experimental cholesteatoma.
Park K; Park HJ; Chun YM
Eur Arch Otorhinolaryngol; 2001 Mar; 258(3):101-5. PubMed ID: 11374247
[TBL] [Abstract][Full Text] [Related]
55. Expression of minichromosome maintenance 5 protein in proliferative and malignant skin diseases.
Liu H; Takeuchi S; Moroi Y; Lin N; Urabe K; Kokuba H; Imafuku S; Dainichi T; Uchi H; Furue M; Tu Y
Int J Dermatol; 2007 Nov; 46(11):1171-6. PubMed ID: 17988337
[TBL] [Abstract][Full Text] [Related]
56. Expression of PCNA and Ki-67 in posterior uveal melanomas in adults.
Proniewska-Skretek E; Dziecioł J; Zalewska R; Mariak Z
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():79-81. PubMed ID: 15638382
[TBL] [Abstract][Full Text] [Related]
57. [Possible role of transforming growth factor alpha on the cholesteatoma growth regulation].
Xu Y; Wu Z; Tao Z; Hua Q; Jin K
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Jan; 17(1):32-4. PubMed ID: 12725186
[TBL] [Abstract][Full Text] [Related]
58. [The study of proliferative epithelial activity in cholesteatoma of the middle ear during cytomorphophotometry].
Amador JM; Esquivias JJ; Ciges M
Acta Otorrinolaringol Esp; 1994; 45(2):71-8. PubMed ID: 8086212
[TBL] [Abstract][Full Text] [Related]
59. Correlation of vascular morphology with clinical types in cholesteatoma of the middle ear.
Stammberger M; Bujía J; Schulz P
Am J Otol; 1994 May; 15(3):380-2. PubMed ID: 8579144
[TBL] [Abstract][Full Text] [Related]
60. [A CT cytomorphodensitometric study of the proliferating epithelial activity in middle ear cholesteatoma].
Amador JM; Esquivias JJ; Ciges M
Acta Otorrinolaringol Esp; 1994; 45(3):153-9. PubMed ID: 8068356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
